(Q37992997)

26 August 2017

title

Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review (English)

1 reference

26 August 2017

1 reference

Sepideh Elyasi

1

1 reference

26 August 2017

Hossein Khalili

series ordinal

2

1 reference

26 August 2017

Simin Dashti-Khavidaki

series ordinal

3

1 reference

26 August 2017

Amirhooshang Mohammadpour

series ordinal

4

1 reference

26 August 2017

publication date

13 March 2012

1 reference

European Journal of Clinical Pharmacology

26 August 2017

published in

1 reference

26 August 2017

volume

68

1 reference

26 August 2017

issue

9

1 reference

26 August 2017

page(s)

1243-1255

1 reference

Decreased renal accumulation and toxicity of a new VCM formulation in rats with chronic renal failure

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Vancomycin ototoxicity and nephrotoxicity. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Mississippi mud in the 1990s: risks and outcomes of vancomycin-associated toxicity in general oncology practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Vancomycin: a 50-year reassessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

21 January 2018

Vancomycin: a history

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Glycopeptides and nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Increasing vancomycin serum trough concentrations and incidence of nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Targeting Superoxide Dismutase to Renal Proximal Tubule Cells Attenuates Vancomycin-induced Nephrotoxicity in Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Protective effects of different antioxidants and amrinone on vancomycin-induced nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Protective effect of inactive ingredients against nephrotoxicity of vancomycin hydrochloride in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Inhibition of vancomycin-induced nephrotoxicity by targeting superoxide dismutase to renal proximal tubule cells in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Heme oxygenase -1 gene therapy: recent advances and therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Oxidative stress: molecular perception and transduction of signals triggering antioxidant gene defenses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Vancomycin-associated nephrotoxicity: grave concern or death by character assassination?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Transporters and renal drug elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Gene expression analysis reveals new possible mechanisms of vancomycin-induced nephrotoxicity and identifies gene markers candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Renal transport of antibiotics and nephrotoxicity: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Applying new diagnostic criteria for acute kidney injury to facilitate early identification of nephrotoxicity in vancomycin-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Acute kidney injury in 2011: Biomarkers are transforming our understanding of AKI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Population pharmacokinetic analysis of vancomycin using serum cystatin C as a marker of renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Recent changes in vancomycin use in renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Lack of vancomycin-associated nephrotoxicity in newborn infants: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Chrononephrotoxicity in rat of a vancomycin and gentamicin combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

A prospective study of adverse reactions associated with vancomycin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Nephrotoxicity due to combination antibiotic therapy with vancomycin and aminoglycosides in septic critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Nephrotoxicity of vancomycin and aminoglycoside therapy separately and in combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

A comparative assessment of vancomycin-associated nephrotoxicity in the young versus the elderly hospitalized patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Vancomycin toxicity: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Do vancomycin serum levels predict failures of vancomycin therapy or nephrotoxicity in cancer patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Incidence and risk factors influencing the development of vancomycin nephrotoxicity in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Elevated vancomycin trough is not associated with nephrotoxicity among inpatient veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Once-daily versus twice-daily intravenous administration of vancomycin for infections in hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Vancomycin during pregnancy: does it cause hearing loss or nephrotoxicity in the infant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-012-1259-9

Association of vancomycin serum concentrations with outcomes in patients with gram-positive bacteremia.

21 January 2018

1 reference

12 December 2020

Influence of fosfomycin and tobramycin on vancomycin-induced nephrotoxicity

1 reference

12 December 2020

[Glycopeptides and the newborn infant's kidney]

1 reference

12 December 2020

Influence of vancomycin on renal function in critically ill patients after cardiac surgery: continuous versus intermittent infusion

1 reference

12 December 2020

Mild nephrotoxicity associated with vancomycin use.

1 reference

12 December 2020

Nephrotoxicity of vancomycin and drug interaction study with cilastatin in rabbits

1 reference

12 December 2020

Nephrotoxicity of gentamicin and vancomycin given alone and in combination as determined by enzymuria and cortical antibiotic levels in rats

1 reference

12 December 2020

Acute renal failure in patients with AIDS on tenofovir while receiving prolonged vancomycin course for osteomyelitis.

1 reference

12 December 2020

Toxicology of vancomycin in laboratory animals

1 reference

12 December 2020

Proliferative responses observed following vancomycin treatment in renal proximal tubule epithelial cells

1 reference

12 December 2020

[Nephrotoxicity and drug interaction of vancomycin (2)]

1 reference

12 December 2020

Safety of vancomycin with or without gentamicin in neonates

1 reference

12 December 2020

Vancomycin nephrotoxicity may be overstated

1 reference

12 December 2020

[Level of evidence for therapeutic drug monitoring of vancomycin]

1 reference

12 December 2020

Risk of nephrotoxicity with combination vancomycin-aminoglycoside antibiotic therapy.

1 reference

12 December 2020

A comparative study of enzymuria, in the rat, of the drug combinations amikacin/vancomycin and amikacin/teicoplanin

1 reference

12 December 2020

Vancomycin-induced nephrotoxicity in rats: is enzyme elevation a consistent finding in tubular injury?

1 reference

12 December 2020

Nephrotoxicity of vancomycin in patients with normal serum creatinine

1 reference

12 December 2020

Renal tolerance and pharmacokinetics of vancomycin in rats

1 reference

12 December 2020

Vancomycin does not enhance amikacin-induced tubular nephrotoxicity in children.

1 reference

12 December 2020

A higher dose of vancomycin in continuous infusion is needed in critically ill patients

1 reference

12 December 2020

Effect of intravenous vancomycin on renal function

1 reference

12 December 2020

Lack of nephrotoxicity in pediatric patients receiving concurrent vancomycin and aminoglycoside therapy

1 reference

12 December 2020

Novel evidence suggesting an anti-oxidant property for erythropoietin on vancomycin-induced nephrotoxicity in a rat model.

1 reference

12 December 2020

Nephrotoxicity of Aminoglycosides, Polypeptides and Cephalosporins in Cancer Patients

1 reference

12 December 2020

10.1007/S00228-012-1259-9

Identifiers

DOI

1 reference

26 August 2017

1 reference